BioSpace News Archive

New Intellectual Property Strengthens Company’s Scientific Thought Leadership in Targeting Hippo Pathway to Combat Cancer.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2021 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, February 17, 2022.

Marinus Pharmaceuticals Completes In Vivo M2 Metabolite Study and Provides European Regulatory Update.

Science 37 Holdings, Inc. today announced a collaboration to help research sponsors use remote biosensors and machine learning to build more robust data sets.

Pharmaceutical Associates, Inc. (PAI) announces that it has acquired all of the generic and branded US marketing authorizations from Teligent Inc. (Teligent) for an undisclosed amount.

American Regent announces the introduction and availability of FDA-approved Vasopressin Injection, USP.

February 3, 2022, collaboration agreement was signed between Allosteric Bioscience, a company founded in 2021 integrating Quantum Computing and Artificial Intelligence with Biomedical sciences to create improved treatments for Aging and Longevity and Polaris Quantum Biotech, a company at the vanguard of Quantum Computing for drug discovery.

Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel targeted protein degradation therapeutics toward historically challenging drug targets.

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced it has received approval from an independent Institutional Review Board (IRB) for the protocol of its upcoming internal clinical trial.

EO Ilan Sobel will deliver a virtual presentation and will conduct investor meetings and industry networking by remote at the event, which this year will be “hybrid” and will include both live and virtual attendees.